Oncternal Therapeutics Inc (ONCT)
9.21
+0.11
(+1.21%)
USD |
NASDAQ |
May 31, 16:00
9.36
+0.15
(+1.63%)
After-Hours: 20:00
Oncternal Therapeutics Enterprise Value: 0.2309M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.2309M |
| May 30, 2024 | -0.0946M |
| May 29, 2024 | -0.065M |
| May 28, 2024 | 0.8231M |
| May 24, 2024 | 0.2309M |
| May 23, 2024 | -0.0946M |
| May 22, 2024 | -0.3906M |
| May 21, 2024 | -1.545M |
| May 20, 2024 | -1.574M |
| May 17, 2024 | -1.397M |
| May 16, 2024 | -0.9085M |
| May 15, 2024 | -0.8641M |
| May 14, 2024 | -1.515M |
| May 13, 2024 | -1.574M |
| May 10, 2024 | -2.820M |
| May 09, 2024 | -1.471M |
| May 08, 2024 | -1.708M |
| May 07, 2024 | -1.811M |
| May 06, 2024 | -0.3906M |
| May 03, 2024 | -1.145M |
| May 02, 2024 | -1.145M |
| May 01, 2024 | -2.610M |
| April 30, 2024 | -2.432M |
| April 29, 2024 | -1.930M |
| April 26, 2024 | -2.492M |
| Date | Value |
|---|---|
| April 25, 2024 | -2.610M |
| April 24, 2024 | -1.737M |
| April 23, 2024 | -1.086M |
| April 22, 2024 | -1.722M |
| April 19, 2024 | -0.8049M |
| April 18, 2024 | -1.574M |
| April 17, 2024 | -0.5386M |
| April 16, 2024 | -1.308M |
| April 15, 2024 | -0.9825M |
| April 12, 2024 | 0.7932M |
| April 11, 2024 | -0.5682M |
| April 10, 2024 | -1.287M |
| April 09, 2024 | -1.515M |
| April 08, 2024 | -0.3906M |
| April 05, 2024 | -1.426M |
| April 04, 2024 | -0.9825M |
| April 03, 2024 | -0.3906M |
| April 02, 2024 | 0.4085M |
| April 01, 2024 | 0.4973M |
| March 28, 2024 | -7.619M |
| March 27, 2024 | -9.986M |
| March 26, 2024 | -10.42M |
| March 25, 2024 | -9.956M |
| March 22, 2024 | -9.927M |
| March 21, 2024 | -10.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-47.57M
Minimum
May 13 2022
352.34M
Maximum
Apr 07 2021
35.43M
Average
18.59M
Median
Oct 01 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.388M |
| Total Expenses (Quarterly) | 8.779M |
| EPS Diluted (Quarterly) | -2.83 |
| Earnings Yield | -133.1% |